RENAL AND CARDIOVASCULAR MECHANISMS OF HYPERTENSION IN OBESITY

被引:177
|
作者
HALL, JE
机构
关键词
NATRIURESIS; KIDNEY; BLOOD PRESSURE; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; OBESITY; INSULIN;
D O I
10.1161/01.HYP.23.3.381
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In all forms of hypertension, including human essential hypertension, pressure natriuresis is reset to higher blood pressures; Because human essential hypertension is a heterogeneous disease, it is likely that there are multiple neurohumoral and intrarenal causes of abnormal pressure natriuresis and increased blood pressure. Weight gain is recognized to be an important contributor to essential hypertension, although the mechanisms that link obesity with altered renal function and high blood pressure have not been fully elucidated. In obese dogs and humans, the shift of pressure natriuresis to higher blood pressures appears to be due mainly to increased tubular reabsorption, as glomerular filtration rate and renal plasma flow are increased compared with normal. Multiple causes of increased tubular reabsorption and hypertension in obesity have been postulated, including insulin resistance and hyperinsulinemia, activation of the sympathetic nervous and renin-angiotensin systems, and physical changes within the kidney itself. Support for the insulin resistance-hyperinsulinemia link between obesity and hypertension has been inferred mainly from acute and epidemiologic studies showing a correlation between insulin and blood pressure. Recent studies suggest that chronic hyperinsulinemia, comparable to that found in obesity, cannot account for obesity hypertension in dogs or humans. Activation of the sympathetic nervous system may play a role in obesity-induced hypertension, and there is evidence for a role of altered intrarenal physical forces caused by histological changes within the renal medulla. The quantitative importance of each of these abnormalities in altering renal function and raising blood pressure in obesity remains to be determined but is an important area of research for understanding human essential hypertension.
引用
收藏
页码:381 / 394
页数:14
相关论文
共 50 条
  • [1] RENAL AND CARDIOVASCULAR MECHANISMS OF HYPERTENSION IN OBESITY
    HALL, JE
    CIRCULATION, 1992, 86 (04) : S5 - S5
  • [2] Hypertension, obesity and cardiovascular disease following renal transplantation
    Teplan, V
    Stribrna, J
    Hanzal, V
    Burgelova, M
    Poledne, R
    Vitko, S
    JOURNAL OF HYPERTENSION, 2005, 23 : S213 - S213
  • [3] Obesity-hypertension: The effects on cardiovascular and renal systems
    Zhang, RB
    Reisin, E
    AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (12) : 1308 - 1314
  • [4] OBESITY-ASSOCIATED HYPERTENSION - HYPERINSULINEMIA AND RENAL MECHANISMS
    HALL, JE
    BRANDS, MW
    HILDEBRANDT, DA
    MIZELLE, HL
    HYPERTENSION, 1992, 19 (01) : I45 - I55
  • [6] Mechanisms of obesity-associated cardiovascular and renal disease
    Hall, JE
    Crook, ED
    Jones, DW
    Wofford, MR
    Dubbert, PM
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (03): : 127 - 137
  • [7] Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis
    Kshatriya, Shilpa
    Reams, Garry P.
    Spear, Robert M.
    Freeman, Ronald H.
    Dietz, John R.
    Villarreal, Daniel
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (01): : 72 - 78
  • [8] Obesity-Induced Hypertension Interaction of Neurohumoral and Renal Mechanisms
    Hall, John E.
    do Carmo, Jussara M.
    da Silva, Alexandre A.
    Wang, Zhen
    Hall, Michael E.
    CIRCULATION RESEARCH, 2015, 116 (06) : 991 - 1006
  • [9] Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension
    Zhang, R
    Thakur, V
    Morse, S
    Reisin, E
    JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (12) : 819 - 827
  • [10] Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension
    R Zhang
    V Thakur
    S Morse
    E Reisin
    Journal of Human Hypertension, 2002, 16 : 819 - 827